What Xstrahl does

Xstrahl is a privately-held medical device company founded in 1999 and headquartered in Surrey, United Kingdom, with operating entities in the United States (Suwanee, Georgia) and Germany. The company designs and manufactures superficial and orthovoltage X-ray therapy systems used to treat non-melanoma skin cancers, keloid scarring, and other benign conditions, alongside image-guided preclinical radiation research platforms used by academic and pharmaceutical researchers. Its clinical portfolio includes the Radiant Aura dual-modality system (combining electronic brachytherapy and orthovoltage in one platform), and the Xstrahl 100/150/200/300 series covering a 50–300 kV energy range. Its research portfolio includes the SARRP image-guided small animal irradiator, SARRP FLASH and CIX FLASH ultra-high dose rate systems, the SARRP Beamline, XenX, and the CIX family of cabinet irradiators, supported by FDA 510(k)-cleared XBeam treatment planning software and Monte Carlo simulation tools (SmART-RAD, MuriSuite, Voxl).

Xstrahl monetizes primarily through direct enterprise sales of high-value capital equipment to hospitals, dermatology clinics, and research institutions, with quote-based pricing ranging from hundreds of thousands to millions of dollars per system. Recurring revenue comes from multi-year technical support, maintenance, post-market surveillance, and the company's 20-year technical training program delivered at its Birmingham, UK facility. The go-to-market blends direct enterprise field sales, inside sales for mid-market accounts, regional distributors (e.g., Nozomi Medical in Uzbekistan), and active participation at clinical and research conferences including AAD, ESTRO, ACRO, and RRS.

The company serves three primary customer segments: dermatologists and dermatology practices (treating NMSC and keloids in office-based settings), radiation oncologists and hospital oncology departments (delivering orthovoltage radiotherapy for skin and head/neck cancers), and life science researchers (using SARRP and CIX systems for translational radiation research including FLASH studies). Notable customers include Duke University, Cancer Research UK Manchester Institute, CRUK RadNet Centre Glasgow, Queens University Belfast, Norfolk & Norwich University Hospitals, Fondazione IRCCS Ca' Granda, and Valley View Hospital. Xstrahl operates as a management-owned private company with no disclosed institutional investors and no M&A activity in the available record.

Name

Xstrahl

Legal name

Xstrahl Ltd

Website

https://xstrahl.com/

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Xstrahl is a privately-held medical device company that designs and manufactures superficial and orthovoltage X-ray therapy systems for treating non-melanoma skin cancers and keloids, plus image-guided preclinical radiation research platforms for academic and pharmaceutical researchers globally.

Ownership category

akta.pro rank

Product category

Radiation Therapy Equipment

NAICS

Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

X-ray & Fluoroscopy Systems (HLAHABAA)

akta.pro secondary industries

Radiation Oncology (HLAKAFAC), Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)

Keywords

• Radiation therapy equipment
• Orthovoltage X-ray systems
• Superficial radiotherapy devices
• Preclinical radiation research
• Electronic brachytherapy systems

Headquarters

HQ city

Suwanee

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Systems Hardware Sales: Sale of capital equipment including clinical radiation therapy systems (Radiant Aura, Xstrahl 100/150/200/300 series) and research systems (SARRP, cabinet irradiators). These are high-value capital purchases with long sales cycles.
2. Professional Services and Training: Technical training courses on X-ray treatment systems, including installation, maintenance, and software operation. Xstrahl has been delivering technical training for over 20 years.
3. Technical Support and Maintenance: Ongoing technical support services including breakdown support, application/software support, service visits, and post-market surveillance for installed systems.
4. Software Licenses: Treatment planning software (XBeam V2) and control software (MuriSuite, Voxl) for research systems, sold as licenses or integrated with hardware.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

Xstrahl designs, manufactures, and sells X-ray radiation therapy and research systems. Its clinical product lines deliver superficial and orthovoltage radiotherapy plus electronic brachytherapy for treating non-melanoma skin cancer, keloid scarring, and benign conditions in dermatology and radiation oncology settings. Its research product lines deliver image-guided small animal irradiators and cabinet irradiators with FLASH ultra-high dose rate capability for translational preclinical radiation research at universities, pharmaceutical companies, and contract research organizations.

Product overview

Xstrahl offers two primary product lines: Clinical Systems for radiation therapy and Research Systems for preclinical radiation research. The clinical portfolio includes Radiant Aura (dual modality eBT/orthovoltage), RADiant, and the Xstrahl 100/150/200/300 series for superficial and orthovoltage radiotherapy treating non-melanoma skin cancers, keloids, and benign conditions. The research portfolio includes SARRP, SARRP FLASH, SARRP Beamline, and XenX image-guided irradiators, plus CIX cabinet irradiators (CIX2, CIX3, CIXD, CIX FLASH) for preclinical studies. Supporting software includes XBeam (FDA-cleared treatment planning), MuriSuite (SARRP control), Voxl (reconstruction engine), and SmART-RAD (Monte Carlo dosimetry tool).

Differentiator

Problem solved

Functional benefit

Brands

• RADiant: Combined electronic brachytherapy and orthovoltage radiotherapy system using low energy photons for skin cancer and keloid treatment
• SARRP
• XBeam
• MuriSuite
• Voxl
• SmART-RAD
• SmART-XPS

Products and services

• Radiant Aura Low-dose X-ray based dual modality radiation therapy system combining electronic brachytherapy (eBT) and orthovoltage radiotherapy in a single platform for treating non-melanoma skin cancers (NMSC) and keloid scarring. FDA 510(k) cleared. Targeted at hospital radiation oncology departments and office-based dermatology practices.
• Xstrahl 100 Superficial radiation therapy system for office-based treatment of superficial skin cancers, particularly non-melanoma skin cancers, in dermatology clinics.
• Xstrahl 150 Superficial radiotherapy system with higher energy levels than competing units, featuring a water-cooling system and an interlock option on the filter selection, for treating skin cancers and keloids in hospital and dermatology settings.
• Xstrahl 200 Orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions, including non-melanoma skin cancer, in hospitals and oncology centers.
• Xstrahl 300 Higher energy radiotherapy system used for definitive radiotherapy treatments of skin cancers and advanced clinical applications, including dermatology photoradiotherapy.
• SARRP (Small Animal Radiation Research Platform) Image-guided Small Animal Radiation Research Platform featuring microCT imaging, conformal irradiation, and Monte Carlo-based treatment planning for preclinical translational radiation research. Over 100 units installed globally including at Duke University.
• SARRP FLASH FLASH radiotherapy research system delivering ultra-high dose rate radiation (exceeding 40 Gy/s) on the SARRP platform, used to study FLASH-effect normal tissue sparing while maintaining tumor-killing efficacy in small animal models.
• SARRP Beamline Research irradiator using beamline technology for advanced preclinical radiation studies, including proton irradiation research.
• XenX Image-guided irradiator system for preclinical radiation research applications.
• CIX3 Cabinet Irradiator Third-generation cabinet irradiator with reduced footprint, safer controls, and larger irradiation chamber, widely used in cancer research centers globally for preclinical studies including clonogenic assays and cell irradiation.
• CIX FLASH FLASH-capability cabinet irradiator for preclinical radiobiology research enabling ultra-high dose rate studies.
• CIX2 Cabinet irradiator for preclinical research enabling clonogenic assays and cell irradiation studies.
• CIXD Cabinet irradiator for preclinical research applications.
• XBeam Treatment Planning Software FDA 510(k)-cleared dose planning software that automates superficial and orthovoltage radiotherapy treatment planning, eliminates risk, and integrates with the Concerto system across Xstrahl medical devices.
• MuriSuite Next-generation control software for SARRP devices providing intuitive control and management of preclinical radiation research workflows.
• Voxl Reconstruction engine for the SARRP enabling advanced image reconstruction for preclinical studies.
• SmART-RAD Monte Carlo simulation tool for X-ray cabinet radiobiology irradiators that simulates X-ray fields for dosimetric validation and treatment planning in preclinical radiobiology research.
• Xstrahl Technical Training and Support Services Technical training courses covering installation, maintenance, and software operation of X-ray treatment systems, together with ongoing technical support including breakdown support, application and software support, service visits, and post-market surveillance for installed Xstrahl systems. Xstrahl has delivered these technical training courses for over 20 years.

Quantifiable outcome

• 100% up time reported by Valley View Hospital after 3+ years of Xstrahl 150 use
• +3 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Nozomi MedicalsignificantChannel Partner/ Reseller/ Distributor · 1 January 2024Nozomi Medical serves as a distribution and installation partner for Xstrahl products in Uzbekistan. Nozomi Medical has installed 12 Xstrahl 200 units for superficial and orthovoltage radiotherapy across Uzbekistan, including at the Republican Oncology Center.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Elekta: Elekta is a global leader in radiation therapy and radiosurgery (Elekta Versa HD, Gamma Knife, brachytherapy afterloaders) and directly competes with Xstrahl in hospital radiation oncology departments, though with a far broader linear accelerator portfolio.
• Varian Medical Systems (Siemens Healthineers): Varian is the dominant external-beam radiotherapy (TrueBeam, Edge) and treatment planning (Eclipse) vendor globally and the principal incumbent competing with Xstrahl's clinical orthovoltage and research SARRP-related workflows.
• Accuray: Accuray's CyberKnife and TomoTherapy systems are image-guided radiotherapy platforms competing for the same hospital capital budgets as Xstrahl's orthovoltage clinical systems in radiation oncology departments.
• Eckert & Ziegler: Eckert & Ziegler supplies radiation therapy products, brachytherapy seeds (IsoCord, IsoSeed), and radiotherapy-related consumables serving overlapping hospital-based cancer treatment customers.
• Revvity (PerkinElmer Life Sciences): Revvity (formerly PerkinElmer) supplies preclinical imaging and radiation research instrumentation; overlaps with Xstrahl's SARRP image-guided irradiator and cabinet irradiator preclinical research customer base.

Direct peers

• IntraOp Medical: IntraOp manufactures the Mobetron, a portable electron-beam intraoperative radiotherapy system; comparable orthovoltage-range radiotherapy capital equipment vendor targeting specialty oncology indications.
• BEBIG Medical (Mick Radio-Nuclear Instruments): BEBIG Medical provides HDR/PDR brachytherapy afterloaders and seeds; competes with Xstrahl's Radiant Aura electronic brachytherapy modality in dermatology and oncology radiation treatment delivery.
• Mevion Medical Systems: Mevion manufactures compact proton therapy systems (MEVION S250) directly competing in the specialty radiotherapy capital equipment category where Xstrahl positions its clinical orthovoltage and image-guided platforms.
• Sensus Healthcare: Sensus Healthcare manufactures the SRT-100 superficial radiation therapy system, the most direct head-to-head competitor to Xstrahl's 100/150/200 series for non-melanoma skin cancer treatment in dermatology practices.

Emerging players

• RaySearch Laboratories: RaySearch develops RayStation and RayCare treatment planning and oncology information systems that overlap with Xstrahl's XBeam and MuriSuite planning/control software offerings for radiation therapy and research workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/Xstrahl_Inc
• YouTubevimeo.com/xstrahl
• Facebookfacebook.com/XstrahlLTD
• LinkedInlinkedin.com/company/xstrahl-limited
• Instagraminstagram.com/xstrahl_srt

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xstrahl